Merge Hemo, Model RCSV2
by Merge Healthcare Incorporated United States 510(k)
510(k) K233326 Product code DQK
Overview
Merge Hemo, Model RCSV2 is a computerized hemoglobin A1c monitoring system that utilizes advanced algorithms and machine learning techniques to provide accurate and reliable blood glucose readings. This innovative device enables healthcare professionals to gain valuable insights into patient health, facilitating timely interventions and improved care outcomes.
Regulatory status
Recall ongoing. 1 ongoing FDA recall. See recalls
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| United States | FDA 510(k)SESE | NumberK233326 | Date21 Jun 2024 | StatusActive |
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not known
- Not covered
United States — FDA 510(k) Active
Recalls
-
- Ongoing Z-2518-2025
Merge Healthcare has been informed by Schiller AG (Baar, Switzerland) of an issue with the Schiller ARGUS PB-3000 Patient Data Module (PDM) where certain units trigger an error message on the Merge Hemo Client (Pressure Sensor Defective) during non-invasive blood pressure (NIBP) measurements, specifically when the initial inflation pressure is set in the high-pressure range (>240 mmHg). The ARGUS PB-3000 is a vital signs monitoring instrument intended to be integrated into the Merge Hemo System. No other components of the Merge Hemo System are affected.
Specification
- 510(k) Number
- FDA Product Code
- DQK
- Device Class
- Class II
- Regulation
- 21 CFR Part 870.1425
- Advisory Committee
- Cardiovascular
- FDA Decision
- SESE Substantially Equivalent
Other devices from Merge Healthcare Incorporated
Properties & raw data
Show properties, registry sources and raw records
Sources (1)
- FDA 510(k) K233326